跳至主要内容
临床试验/NCT00510705
NCT00510705终止不适用

Chronic Inflammatory Activation in Fat Tissue: An Atherogenic Factor in Severe Coronary Artery Disease

University of Leipzig2 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2007年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
29
试验地点
2
主要终点
change in endothelial function in severe coronary artery disease

研究概览

简要总结

Chronic inflammatory activation in fat tissue can be the link between adiposity and an increased risk for atherosclerosis. The aim of this study is to investigate how molecular alterations in fat tissue can be influenced by regular physical exercise training alone or in combination with a medical therapy (glitazone or metformin) in obese patients with severe coronary artery disease (CAD) and impaired glucose tolerance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
35 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Either impaired glucose tolerance (2 hour plasma glucose concentration > 7.8 and < 11.1 mmol/L during an oral glucose tolerance test) or impaired fasting plasma glucose concentration ( > 6.0 and < 7.0 mmol/L)
  • Body mass index (BMI) > 25
  • Severe coronary artery disease determined by coronary angiography
  • Male patients aged 35-75 years

排除标准

  • Diabetes mellitus type I
  • Diabetes mellitus type II in combination with glycosylates hemoglobin > 6.0%, previous medication with oral antidiabetic agents or insulin, fasting plasma glucose concentration > 11.0 mmol/L
  • Unstable angina pectoris
  • Myocardial infarction within the last 4 weeks
  • Reduced left-ventricular systolic function < 30%

结局指标

主要结局

change in endothelial function in severe coronary artery disease

时间窗: 4 weeks

次要结局

  • change in metabolic parameters(4 weeks)

研究者

发起方
University of Leipzig
申办方类型
Other
责任方
Principal Investigator
主要研究者

Axel Linke

Co-Investigator

University of Leipzig

研究点 (2)

Loading locations...

相似试验

Chronic Inflammatory Activation in Fat Tissue: An... | 临床试验